These range from manufacturer-sponsored savings cards to income-based patient assistance programs that provide medications at no cost
Patients taking combination therapy should be particularly vigilant for these symptoms
Abbreviations BGM Blood glucose monitoring CGM Continuous glucose monitoring CSII Continuous subcutaneous insulin infusion CVOT Cardiovascular outcomes trial DKA Diabetic ketoacidosis DPP-4i Dipeptidyl peptidase-4 inhibitors DSMES Diabetes self-management education and support ETD Estimated treatment difference GIP Glucose-dependent insulinotropic polypeptide GLP-1 RA Glucagon-like peptide-1 receptor agonist(s) HF Heart failure HHF Hospitalisation for heart failure MACE Major adverse cardiovascular events MNT Medical nutrition therapy NAFLD Non-alcoholic fatty liver disease NASH Non-alcoholic steatohepatitis SGLT1i Sodiumglucose cotransporter-1 inhibitor SGLT2i Sodiumglucose cotransporter-2 inhibitor(s) TZD Thiazolidinedione UACR Urinary albumin/creatinine ratio Funding This activity was funded by the American Diabetes Association and the European Association for the Study of Diabetes
Prevention and treatment of opioid misuse and addiction: a review
LIMITATIONS, REASONS FOR CAUTION Study limitations include the absence of data regarding medication compliance post prescription redemption, potential misclassification due to parallel importation, and the inability to control for unmeasured confounding factors
To break a weight loss plateau on semaglutide, I recommend reviewing your nutrition, increasing protein, adjusting your exercise routine, and tracking body compositionnot just the scale
